Annual Total Liabilities
$40.23 M
-$16.75 M-29.40%
December 31, 2023
Summary
- As of February 22, 2025, ACRS annual total liabilities is $40.23 million, with the most recent change of -$16.75 million (-29.40%) on December 31, 2023.
- During the last 3 years, ACRS annual total liabilities has risen by +$7.09 million (+21.40%).
- ACRS annual total liabilities is now -33.45% below its all-time high of $60.44 million, reached on December 31, 2018.
Performance
ACRS Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$52.24 M
+$24.99 M+91.72%
September 30, 2024
Summary
- As of February 22, 2025, ACRS quarterly total liabilities is $52.24 million, with the most recent change of +$24.99 million (+91.72%) on September 30, 2024.
- Over the past year, ACRS quarterly total liabilities has dropped by -$9.78 million (-15.77%).
- ACRS quarterly total liabilities is now -34.86% below its all-time high of $80.20 million, reached on September 30, 2015.
Performance
ACRS Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ACRS Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.4% | -15.8% |
| 3 y3 years | +21.4% | +11.4% |
| 5 y5 years | -33.5% | -30.5% |
ACRS Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -29.4% | at low | -15.8% | +91.7% |
| 5 y | 5-year | -29.4% | +41.7% | -15.8% | +91.7% |
| alltime | all time | -33.5% | +2486.9% | -34.9% | +3561.0% |
Aclaris Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $52.24 M(+91.7%) |
| Jun 2024 | - | $27.25 M(-15.0%) |
| Mar 2024 | - | $32.05 M(-20.3%) |
| Dec 2023 | $40.23 M(-29.4%) | $40.23 M(-35.1%) |
| Sep 2023 | - | $62.02 M(+11.0%) |
| Jun 2023 | - | $55.90 M(+5.7%) |
| Mar 2023 | - | $52.90 M(-7.2%) |
| Dec 2022 | $56.98 M(+5.8%) | $56.98 M(+19.2%) |
| Sep 2022 | - | $47.79 M(+13.2%) |
| Jun 2022 | - | $42.22 M(-8.9%) |
| Mar 2022 | - | $46.33 M(-14.0%) |
| Dec 2021 | $53.87 M(+62.6%) | $53.87 M(+14.8%) |
| Sep 2021 | - | $46.91 M(-13.5%) |
| Jun 2021 | - | $54.23 M(+10.4%) |
| Mar 2021 | - | $49.10 M(+48.2%) |
| Dec 2020 | $33.13 M(+16.7%) | $33.13 M(+6.4%) |
| Sep 2020 | - | $31.14 M(-12.6%) |
| Jun 2020 | - | $35.63 M(-7.8%) |
| Mar 2020 | - | $38.64 M(+36.1%) |
| Dec 2019 | $28.39 M | $28.39 M(-62.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $75.14 M(-6.1%) |
| Jun 2019 | - | $80.01 M(+12.8%) |
| Mar 2019 | - | $70.93 M(+17.4%) |
| Dec 2018 | $60.44 M(+231.2%) | $60.44 M(+102.5%) |
| Sep 2018 | - | $29.85 M(+8.1%) |
| Jun 2018 | - | $27.62 M(+37.1%) |
| Mar 2018 | - | $20.15 M(+10.4%) |
| Dec 2017 | $18.25 M(+176.7%) | $18.25 M(+6.5%) |
| Sep 2017 | - | $17.13 M(+97.7%) |
| Jun 2017 | - | $8.66 M(+46.3%) |
| Mar 2017 | - | $5.92 M(-10.2%) |
| Dec 2016 | $6.59 M(+324.1%) | $6.59 M(+33.3%) |
| Sep 2016 | - | $4.95 M(-15.4%) |
| Jun 2016 | - | $5.85 M(+44.2%) |
| Mar 2016 | - | $4.06 M(+161.0%) |
| Dec 2015 | $1.55 M(-95.9%) | $1.55 M(-98.1%) |
| Sep 2015 | - | $80.20 M(+5520.5%) |
| Jun 2015 | - | $1.43 M(-96.3%) |
| Dec 2014 | $38.13 M(+63.2%) | $38.13 M |
| Dec 2013 | $23.37 M | - |
FAQ
- What is Aclaris Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Aclaris Therapeutics?
- What is Aclaris Therapeutics annual total liabilities year-on-year change?
- What is Aclaris Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Aclaris Therapeutics?
- What is Aclaris Therapeutics quarterly total liabilities year-on-year change?
What is Aclaris Therapeutics annual total liabilities?
The current annual total liabilities of ACRS is $40.23 M
What is the all time high annual total liabilities for Aclaris Therapeutics?
Aclaris Therapeutics all-time high annual total liabilities is $60.44 M
What is Aclaris Therapeutics annual total liabilities year-on-year change?
Over the past year, ACRS annual total liabilities has changed by -$16.75 M (-29.40%)
What is Aclaris Therapeutics quarterly total liabilities?
The current quarterly total liabilities of ACRS is $52.24 M
What is the all time high quarterly total liabilities for Aclaris Therapeutics?
Aclaris Therapeutics all-time high quarterly total liabilities is $80.20 M
What is Aclaris Therapeutics quarterly total liabilities year-on-year change?
Over the past year, ACRS quarterly total liabilities has changed by -$9.78 M (-15.77%)